REG - Hikma Pharmaceutical - Director Declaration

Hikma PharmaceuticalsAnnouncement

27/06/2024 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240627:nRSa2000Ua&default-theme=true

RNS Number : 2000U  Hikma Pharmaceuticals Plc  27 June 2024

Hikma Pharmaceuticals PLC

Director Declaration

In accordance with Listing Rule 9.6.14, Hikma Pharmaceuticals PLC announces
that Victoria Hull, Senior Independent Non-Executive Director, has been
appointed as a Non-Executive Director of Serco Group PLC with effect from 1
September 2024.

- ENDS -

 

Enquiries:

 

 Hikma Pharmaceuticals PLC
 Helen Middlemist           +44 20 7399 2760

 Group Company Secretary

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RDNFRMTTMTITBFI